Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Effects of statin therapy on the production of monocyte pro-inflammatory cytokines, cardiac function, and long-term prognosis in chronic heart failure patients with dyslipidemia.

Nakagomi A, Seino Y, Kohashi K, Kosugi M, Endoh Y, Kusama Y, Atarashi H, Mizuno K.

Circ J. 2012;76(9):2130-8. Epub 2012 Jun 13.

2.

Relationships between the serum cholesterol levels, production of monocyte proinflammatory cytokines and long-term prognosis in patients with chronic heart failure.

Nakagomi A, Seino Y, Noma S, Kohashi K, Kosugi M, Kato K, Kusama Y, Atarashi H, Shimizu W.

Intern Med. 2014;53(21):2415-24. Epub 2014 Nov 1.

3.

Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia.

Kohashi K, Nakagomi A, Saiki Y, Morisawa T, Kosugi M, Kusama Y, Atarashi H, Shimizu W.

J Atheroscler Thromb. 2014;21(7):712-29. Epub 2014 Mar 27.

5.

Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.

Krum H, Bailey M, Meyer W, Verkenne P, Dargie H, Lechat P, Anker S.

Cardiology. 2007;108(1):28-34. Epub 2006 Sep 8.

PMID:
16960445
6.

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV.

J Am Coll Cardiol. 2006 Jan 17;47(2):332-7. Epub 2005 Dec 20.

7.

Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.

Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H.

Int J Cardiol. 2005 Aug 18;103(2):182-6.

PMID:
16080978
8.

Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure.

Oyama J, Kudo Y, Maeda T, Node K, Makino N.

Heart Vessels. 2013 Mar;28(2):173-8. doi: 10.1007/s00380-011-0220-7. Epub 2012 Jan 11.

PMID:
22231540
9.

The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.

Gürgün C, Ildizli M, Yavuzgil O, Sin A, Apaydin A, Cinar C, Kültürsay H.

Int J Cardiol. 2008 Jan 11;123(2):102-7. Epub 2007 Feb 22.

PMID:
17320212
10.

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.

Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M.

J Am Coll Cardiol. 2000 Nov 1;36(5):1587-93.

11.

Intracellular monocyte cytokine production and CD 14 expression are up-regulated in severe vs mild chronic heart failure.

Conraads VM, Bosmans JM, Schuerwegh AJ, Goovaerts I, De Clerck LS, Stevens WJ, Bridts CH, Vrints CJ.

J Heart Lung Transplant. 2005 Jul;24(7):854-9.

PMID:
15982613
12.

Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.

Tekin A, Sezgin N, Katircibaşi MT, Tekin G, Cölkesen Y, Sezgin AT, Müderrisoğlu H.

Coron Artery Dis. 2008 Nov;19(7):513-9. doi: 10.1097/MCA.0b013e32830d27d2.

PMID:
18923248
13.

Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.

Sola S, Mir MQ, Rajagopalan S, Helmy T, Tandon N, Khan BV.

J Card Fail. 2005 Oct;11(8):607-12.

PMID:
16230264
14.

Effects of preoperative statin therapy on cytokines after cardiac surgery.

Liakopoulos OJ, Dörge H, Schmitto JD, Nagorsnik U, Grabedünkel J, Schoendube FA.

Thorac Cardiovasc Surg. 2006 Jun;54(4):250-4.

PMID:
16755446
15.
16.

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.

Yamada T, Node K, Mine T, Morita T, Kioka H, Tsukamoto Y, Tamaki S, Masuda M, Okuda K, Fukunami M.

Am Heart J. 2007 Jun;153(6):1055.e1-8.

PMID:
17540209
17.

Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure.

Xie RQ, Cui W, Liu F, Yang C, Pei WN, Lu JC.

Int J Cardiol. 2010 Apr 15;140(2):255-7. doi: 10.1016/j.ijcard.2008.11.030. Epub 2008 Nov 29.

PMID:
19042044
18.

Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates.

Okopień B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M, Herman ZS.

J Cardiovasc Pharmacol. 2005 Sep;46(3):377-86.

PMID:
16116345
20.

Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.

Abulhul E, McDonald K, Martos R, Phelan D, Spiers JP, Hennessy M, Baugh J, Watson C, O'Loughlin C, Ledwidge M.

Clin Ther. 2012 Jan;34(1):91-100. doi: 10.1016/j.clinthera.2011.11.002. Epub 2011 Dec 9.

PMID:
22154198
Items per page

Supplemental Content

Write to the Help Desk